GILD Gilead Sciences
$144.23 -0.28%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.28%
YTD
+23.50%
P/E
21.05
P/B
6.71
ROE
-16.3%
Div yield
4.0%
Beta
0.34
Market cap
$179.1B
RSI (14)
43
Next earnings
Oct 22, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$145.11
Close
$144.23
VWAP (n/a)
—
Day high
$146.14
Day low
$142.60
Volume
3.7M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
Yahoo Finance · Oct 6
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
Yahoo Finance · Oct 5
Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says
Yahoo Finance · Oct 2
More Upside Awaits for Gilead Sciences Stock. Stay Invested.
Yahoo Finance · Oct 2
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance · Oct 1
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors
Yahoo Finance · Sep 30
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 6, 2026 View → 8-K Aug 4, 2026 View → 8-K May 20, 2026 View → 10-Q May 7, 2026 View → 8-K May 7, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell GILD. Try it in the Lab to size a position and see the risk.